PA
BBWI icon

PharVision Advisers’s Bath & Body Works BBWI Stock Holding History

PharVision Advisers’s Portfolio BBWI Stock Details BBWI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,344
Closed -$253K – 283
2025
Q1 		$253K Sell
8,344
-1,043
-11% -$36.9K 0.35% 137
2024
Q4 		$364K Buy
+9,387
New +$314K 0.31% 98

Other funds holding BBWI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PharVision Advisers's BBWI Position: Q2 2025 in Review

PharVision Advisers sold out of Bath & Body Works (BBWI) in Q2 2025, closing a stake of 8,344 shares — an estimated $253K sold.

PharVision Advisers first reported a position in BBWI in Q4 2024 and held it in 2 quarters. The position peaked at $364K in Q4 2024. 472 funds tracked by Wall St. Rank hold BBWI as of Q2 2025.

  • PharVision Advisers reported no remaining Bath & Body Works position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,344 Bath & Body Works shares in Q2 2025, an estimated $253K.
  • PharVision Advisers first reported a position in Bath & Body Works in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Bath & Body Works position peaked at $364K in Q4 2024.
  • 472 funds tracked by Wall St. Rank held Bath & Body Works as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.